These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 29941696

  • 1. Bone Mineral Content and Density in Indian Children with Congenital Adrenal Hyperplasia.
    Ganesh R, Suresh N, Janakiraman L.
    Indian Pediatr; 2018 Oct 15; 55(10):880-882. PubMed ID: 29941696
    [Abstract] [Full Text] [Related]

  • 2. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia.
    Ganesh R, Suresh N, Janakiraman L, Ravikumar K.
    Indian J Pediatr; 2016 Feb 15; 83(2):126-30. PubMed ID: 26223873
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
    Sahakitrungruang T, Wacharasindhu S, Supornsilchai V, Srivuthana S, Kingpetch K.
    J Med Assoc Thai; 2008 May 15; 91(5):705-10. PubMed ID: 18672636
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency.
    Elnecave RH, Kopacek C, Rigatto M, Keller Brenner J, Sisson de Castro JA.
    J Pediatr Endocrinol Metab; 2008 Dec 15; 21(12):1155-62. PubMed ID: 19189689
    [Abstract] [Full Text] [Related]

  • 5. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency.
    Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S.
    J Clin Endocrinol Metab; 2006 Nov 15; 91(11):4453-8. PubMed ID: 16926248
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia.
    Cetinkaya S, Kara C.
    J Pediatr Endocrinol Metab; 2011 Nov 15; 24(5-6):265-9. PubMed ID: 21823521
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral status, bone turnover markers and vitamin D status in children with congenital adrenal hyperplasia.
    Okten A, Cakir M, Makuloglu M.
    Minerva Endocrinol; 2012 Sep 15; 37(3):275-82. PubMed ID: 22766894
    [Abstract] [Full Text] [Related]

  • 9. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
    Guo CY, Weetman AP, Eastell R.
    Clin Endocrinol (Oxf); 1996 Nov 15; 45(5):535-41. PubMed ID: 8977749
    [Abstract] [Full Text] [Related]

  • 10. Bone mineral density and body composition in children with congenital adrenal hyperplasia.
    Halper A, Sanchez B, Hodges JS, Kelly AS, Dengel D, Nathan BM, Petryk A, Sarafoglou K.
    Clin Endocrinol (Oxf); 2018 Jun 15; 88(6):813-819. PubMed ID: 29460378
    [Abstract] [Full Text] [Related]

  • 11. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
    Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K.
    Clin Endocrinol (Oxf); 2019 Jul 15; 91(1):124-130. PubMed ID: 31070802
    [Abstract] [Full Text] [Related]

  • 12. Bone density in young patients with congenital adrenal hyperplasia.
    Mora S, Saggion F, Russo G, Weber G, Bellini A, Prinster C, Chiumello G.
    Bone; 1996 Apr 15; 18(4):337-40. PubMed ID: 8726391
    [Abstract] [Full Text] [Related]

  • 13. [Estimation of influence of congenital-adrenal hyperplasia treatment on bone mineralisation evaluated with densitometry].
    Romanowska H, Krzywińska-Zdeb E, Giżewska M, Kotkowiak L, Safranow K, Horodnicka-Józwa A, Petriczko E, Krupa B, Walczak M.
    Pediatr Endocrinol Diabetes Metab; 2012 Apr 15; 18(1):21-6. PubMed ID: 22525687
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bone mineral density and fractures in congenital adrenal hyperplasia: Findings from the dsd-LIFE study.
    Riehl G, Reisch N, Roehle R, Claahsen van der Grinten H, Falhammar H, Quinkler M.
    Clin Endocrinol (Oxf); 2020 Apr 15; 92(4):284-294. PubMed ID: 31886890
    [Abstract] [Full Text] [Related]

  • 16. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency.
    Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K, Thorén M.
    J Clin Endocrinol Metab; 2007 Dec 15; 92(12):4643-9. PubMed ID: 17878254
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia.
    Ünal S, Alikaşifoğlu A, Özön A, Gönç N, Kandemir N.
    Turk J Pediatr; 2020 Dec 15; 62(3):359-366. PubMed ID: 32558409
    [Abstract] [Full Text] [Related]

  • 19. Association of androgen excess and bone mineral density in women with classical congenital adrenal hyperplasia with 21-hydroxylase deficiency.
    Lee DH, Kong SH, Jang HN, Ahn CH, Lim SG, Lee YA, Kim SW, Kim JH.
    Arch Osteoporos; 2022 Mar 08; 17(1):45. PubMed ID: 35258698
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.